GB1442283A - Orally applicable immunoglobulin composition - Google Patents

Orally applicable immunoglobulin composition

Info

Publication number
GB1442283A
GB1442283A GB4942174A GB4942174A GB1442283A GB 1442283 A GB1442283 A GB 1442283A GB 4942174 A GB4942174 A GB 4942174A GB 4942174 A GB4942174 A GB 4942174A GB 1442283 A GB1442283 A GB 1442283A
Authority
GB
United Kingdom
Prior art keywords
immunoglobulin composition
nov
orally applicable
applicable immunoglobulin
orally
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB4942174A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BIOKEMA SA
Original Assignee
BIOKEMA SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BIOKEMA SA filed Critical BIOKEMA SA
Publication of GB1442283A publication Critical patent/GB1442283A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/04—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from milk
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1228—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K16/1232—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia from Escherichia (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
GB4942174A 1973-11-28 1974-11-15 Orally applicable immunoglobulin composition Expired GB1442283A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1669273A CH590064A5 (enrdf_load_stackoverflow) 1973-11-28 1973-11-28

Publications (1)

Publication Number Publication Date
GB1442283A true GB1442283A (en) 1976-07-14

Family

ID=4419439

Family Applications (1)

Application Number Title Priority Date Filing Date
GB4942174A Expired GB1442283A (en) 1973-11-28 1974-11-15 Orally applicable immunoglobulin composition

Country Status (4)

Country Link
CH (1) CH590064A5 (enrdf_load_stackoverflow)
DE (1) DE2409862C3 (enrdf_load_stackoverflow)
FR (1) FR2253533B1 (enrdf_load_stackoverflow)
GB (1) GB1442283A (enrdf_load_stackoverflow)

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4748018A (en) * 1984-02-07 1988-05-31 Stolle Research & Development Corp. Method of passive immunization of mammals using avian antibody
WO1989007948A1 (en) * 1988-02-26 1989-09-08 Stolle Research & Development Corporation Antihypertensive hyperimmune milk, production, composition, and use
US4956349A (en) * 1983-10-27 1990-09-11 Stolle Research & Development Corporation Anti-inflammatory factor, method of isolation, and use
US5130128A (en) * 1982-06-03 1992-07-14 Stolle Research & Development Corporation Use of honey as vaccine
US5194255A (en) * 1982-06-03 1993-03-16 Stolle Research & Development Corporation Antihypertensive hyperimmune milk, production, composition, and use
US5215746A (en) * 1982-06-03 1993-06-01 Stolle Research And Development Corporation Anti-cholesterolemic egg, vaccine and method for production, and use
US5242691A (en) * 1982-06-03 1993-09-07 Stolle Research & Development Corporation Anti-inflammatory factor, method of isolation, and use
US5352462A (en) * 1982-06-03 1994-10-04 Stolle Research & Development Corporation Anti-inflammatory factor, method of isolation, and use
US5538727A (en) * 1982-06-03 1996-07-23 Dcv Biologics, L.P. Anti-cholesterolemic vaccine
US5650175A (en) * 1982-06-03 1997-07-22 Stolle Research & Development Corporation Anti-inflammatory factor, method of isolation, and use
US5700465A (en) * 1994-01-05 1997-12-23 American Cyanamid Company Bovine serum and bovine IgG as preventives and therapeutives for bovine mastitis
US5849349A (en) * 1982-06-03 1998-12-15 Dcv, Inc. Anti-cholesterolemic egg, vaccine and method for production, and use
US5853765A (en) * 1982-06-03 1998-12-29 Dcv, Inc. Anti-cholesterolemic egg, vaccine and method for production, and use
US5980953A (en) * 1994-10-03 1999-11-09 Stolle Milk Biologics, Inc. Anti-inflammatory factor, method of isolation, and use

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0064210B2 (en) * 1981-05-01 1991-03-06 Miles Inc. Oral pharmaceutical composition containing immune globulin

Cited By (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5352462A (en) * 1982-06-03 1994-10-04 Stolle Research & Development Corporation Anti-inflammatory factor, method of isolation, and use
US5538727A (en) * 1982-06-03 1996-07-23 Dcv Biologics, L.P. Anti-cholesterolemic vaccine
US5932250A (en) * 1982-06-03 1999-08-03 Dcv, Inc. Anti-cholesterolemic egg, vaccine and method for production, and use
US5853765A (en) * 1982-06-03 1998-12-29 Dcv, Inc. Anti-cholesterolemic egg, vaccine and method for production, and use
US5130128A (en) * 1982-06-03 1992-07-14 Stolle Research & Development Corporation Use of honey as vaccine
US5194255A (en) * 1982-06-03 1993-03-16 Stolle Research & Development Corporation Antihypertensive hyperimmune milk, production, composition, and use
US5215746A (en) * 1982-06-03 1993-06-01 Stolle Research And Development Corporation Anti-cholesterolemic egg, vaccine and method for production, and use
US5242691A (en) * 1982-06-03 1993-09-07 Stolle Research & Development Corporation Anti-inflammatory factor, method of isolation, and use
US5849349A (en) * 1982-06-03 1998-12-15 Dcv, Inc. Anti-cholesterolemic egg, vaccine and method for production, and use
US5650175A (en) * 1982-06-03 1997-07-22 Stolle Research & Development Corporation Anti-inflammatory factor, method of isolation, and use
US5753268A (en) * 1982-06-03 1998-05-19 Dcv Biologics, L.P. Anti-cholesterolemic egg, vaccine and method for production, and use
US4956349A (en) * 1983-10-27 1990-09-11 Stolle Research & Development Corporation Anti-inflammatory factor, method of isolation, and use
US4879110A (en) * 1983-10-27 1989-11-07 Stolle Research And Development Corporation Antihypertensive hyperimmune milk, production, composition, and use
US4748018A (en) * 1984-02-07 1988-05-31 Stolle Research & Development Corp. Method of passive immunization of mammals using avian antibody
WO1989007948A1 (en) * 1988-02-26 1989-09-08 Stolle Research & Development Corporation Antihypertensive hyperimmune milk, production, composition, and use
US5700465A (en) * 1994-01-05 1997-12-23 American Cyanamid Company Bovine serum and bovine IgG as preventives and therapeutives for bovine mastitis
US5980953A (en) * 1994-10-03 1999-11-09 Stolle Milk Biologics, Inc. Anti-inflammatory factor, method of isolation, and use

Also Published As

Publication number Publication date
DE2409862C3 (de) 1981-01-08
DE2409862A1 (de) 1975-06-12
DE2409862B2 (de) 1980-04-30
FR2253533A1 (enrdf_load_stackoverflow) 1975-07-04
CH590064A5 (enrdf_load_stackoverflow) 1977-07-29
FR2253533B1 (enrdf_load_stackoverflow) 1978-06-30

Similar Documents

Publication Publication Date Title
GB1442283A (en) Orally applicable immunoglobulin composition
DE2962569D1 (en) Immune serum globulin preparations and method to produce them
Saluk et al. The unique molecular weight of the heavy chain from human IgG3
Hill et al. Horse Anti-SI Immunoglobulins. I. Properties of γM-Antibody
IT8023226A0 (it) Sistema per l'infusione di medicamenti, controllato magneticamente.
NL171270C (nl) Werkwijze voor de bereiding van 1,2,3,4,6,7,12,12a-octahydropyrazinoŸ2',1':6,1Ÿ pyridoŸ3,4-bŸindolen en werkwijze voor de bereiding van preparaten die ze bevatten.
Bona et al. Structure of the lymphocyte membrane. II. Evidence of two classes of Ig on the surface of rabbit lymphocytes during primary response to sheep red blood cells using inhibition of rosette-forming cells and combined ultrastructural autoradiographic and peroxydase methods
IE32975B1 (en) A process for the manufacture of isoindole derivatives
AT292710B (de) Verfahren zur Herstellung von neuen 5-subst.Amino-6-halogen-1H-imidazo[4,5-b]pyrazin-2-onen
IE34609B1 (en) Antineoplastic therapeutic compositions
DE3570677D1 (en) Acino-foetal differentiation proteins associated with cancer of the pancreas, antiserum and monoclonal antibodies against these proteins and processes for their preparation
Ourth et al. Antibody activities of 19S and 7S globulin fractions from rabbit antisera to tetanus toxoid
GB1339737A (en) Diagnostic agents for primary hepatoma
DK127421B (da) Fremgangsmåde til fremstilling af cardenolid-3[2',3'-didesoxyglycosider].
GB1263677A (en) Process for the preparation of quinoxaline-di-n-oxide-aldehyde
GB1199951A (en) Modified Dextran and Derivatives Thereof
Yamauchi Studies on the Mechanism of Antibody Formation
GB1416544A (en) Immunizing agents for bacterial infections
GB1330805A (en) Immunization methods against toxic effects of bacterial infection
GB1177610A (en) A Process for the Preparation of Benzodiazepine Derivatives
GB1463908A (en) 1-dimethylamino-methyl-6-substituted-4h-s-triazolo-4,3-a- 1,4-benzodiazepine
Suvanprakorn Determination of formation constants for the binding of methylmercury by the amino group of selected aminocarboxylic acids
Barber Unusual antigenic composition of an Arizona strain
Bowman Close Corporations, Vol. 2
Romanski High-Temperature Corrosion of Fe-Al Alloys in S Vapour

Legal Events

Date Code Title Description
PS Patent sealed
PCNP Patent ceased through non-payment of renewal fee